<VariationArchive VariationID="934045" VariationName="NM_003001.5(SDHC):c.349_350del (p.Lys117fs)" VariationType="Deletion" Accession="VCV000934045" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="930130" VariationID="934045">
      <GeneList>
        <Gene Symbol="SDHC" FullName="succinate dehydrogenase complex subunit C" GeneID="6391" HGNC_ID="HGNC:10682" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161314381" stop="161363206" display_start="161314381" display_stop="161363206" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161284165" stop="161334540" display_start="161284165" display_stop="161334540" Strand="+" />
          </Location>
          <OMIM>602413</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_003001.5(SDHC):c.349_350del (p.Lys117fs)</Name>
      <CanonicalSPDI>NC_000001.11:161356783:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="161356784" stop="161356785" display_start="161356784" display_stop="161356785" variantLength="2" positionVCF="161356783" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="161326574" stop="161326575" display_start="161326574" display_stop="161326575" variantLength="2" positionVCF="161326573" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K64fs</ProteinChange>
      <ProteinChange>K83fs</ProteinChange>
      <ProteinChange>K117fs</ProteinChange>
      <ProteinChange>K80fs</ProteinChange>
      <ProteinChange>K98fs</ProteinChange>
      <ProteinChange>K157fs</ProteinChange>
      <ProteinChange>K81fs</ProteinChange>
      <ProteinChange>K96fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.161326574_161326575del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.161326574_161326575del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.161356784_161356785del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.161356784_161356785del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012767.1" sequenceAccession="NG_012767" sequenceVersion="1" change="g.47409_47410del">
            <Expression>NG_012767.1:g.47409_47410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035512.3" sequenceAccession="NM_001035512" sequenceVersion="3" change="c.247_248del">
            <Expression>NM_001035512.3:c.247_248del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001030589.1" sequenceAccession="NP_001030589" sequenceVersion="1" change="p.Lys83fs">
            <Expression>NP_001030589.1:p.Lys83fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035513.3" sequenceAccession="NM_001035513" sequenceVersion="3" change="c.190_191del">
            <Expression>NM_001035513.3:c.190_191del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001030590.1" sequenceAccession="NP_001030590" sequenceVersion="1" change="p.Lys64fs">
            <Expression>NP_001030590.1:p.Lys64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407115.1" sequenceAccession="NM_001407115" sequenceVersion="1" change="c.469_470del">
            <Expression>NM_001407115.1:c.469_470del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394044.1" sequenceAccession="NP_001394044" sequenceVersion="1" change="p.Lys157fs">
            <Expression>NP_001394044.1:p.Lys157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407116.1" sequenceAccession="NM_001407116" sequenceVersion="1" change="c.292_293del">
            <Expression>NM_001407116.1:c.292_293del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394045.1" sequenceAccession="NP_001394045" sequenceVersion="1" change="p.Lys98fs">
            <Expression>NP_001394045.1:p.Lys98fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407117.1" sequenceAccession="NM_001407117" sequenceVersion="1" change="c.286_287del">
            <Expression>NM_001407117.1:c.286_287del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394046.1" sequenceAccession="NP_001394046" sequenceVersion="1" change="p.Lys96fs">
            <Expression>NP_001394046.1:p.Lys96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407118.1" sequenceAccession="NM_001407118" sequenceVersion="1" change="c.241_242del">
            <Expression>NM_001407118.1:c.241_242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394047.1" sequenceAccession="NP_001394047" sequenceVersion="1" change="p.Lys81fs">
            <Expression>NP_001394047.1:p.Lys81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407119.1" sequenceAccession="NM_001407119" sequenceVersion="1" change="c.238_239del">
            <Expression>NM_001407119.1:c.238_239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394048.1" sequenceAccession="NP_001394048" sequenceVersion="1" change="p.Lys80fs">
            <Expression>NP_001394048.1:p.Lys80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407120.1" sequenceAccession="NM_001407120" sequenceVersion="1" change="c.238_239del">
            <Expression>NM_001407120.1:c.238_239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001394049.1" sequenceAccession="NP_001394049" sequenceVersion="1" change="p.Lys80fs">
            <Expression>NP_001394049.1:p.Lys80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003001.3" sequenceAccession="NM_003001" sequenceVersion="3" change="c.349_350delAA">
            <Expression>NM_003001.3:c.349_350delAA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002992.1" sequenceAccession="NP_002992" sequenceVersion="1" change="p.Lys117Valfs">
            <Expression>NP_002992.1:p.Lys117Valfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003001.5" sequenceAccession="NM_003001" sequenceVersion="5" change="c.349_350del" MANESelect="true">
            <Expression>NM_003001.5:c.349_350del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002992.1" sequenceAccession="NP_002992" sequenceVersion="1" change="p.Lys117fs">
            <Expression>NP_002992.1:p.Lys117fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_103459.3" sequenceAccession="NR_103459" sequenceVersion="3" change="n.401_402del">
            <Expression>NR_103459.3:n.401_402del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001035511.3" sequenceAccession="NM_001035511" sequenceVersion="3" change="c.242-5545_242-5544del">
            <Expression>NM_001035511.3:c.242-5545_242-5544del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278172.3" sequenceAccession="NM_001278172" sequenceVersion="3" change="c.140-5545_140-5544del">
            <Expression>NM_001278172.3:c.140-5545_140-5544del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407121.1" sequenceAccession="NM_001407121" sequenceVersion="1" change="c.185-5545_185-5544del">
            <Expression>NM_001407121.1:c.185-5545_185-5544del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_317" sequenceAccession="LRG_317">
            <Expression>LRG_317:g.47409_47410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_317t1" sequenceAccession="LRG_317t1">
            <Expression>LRG_317t1:c.349_350del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1672291512" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003001.5(SDHC):c.349_350del (p.Lys117fs) AND multiple conditions" Accession="RCV001202377" Version="7">
        <ClassifiedConditionList TraitSetID="23697">
          <ClassifiedCondition DB="MedGen" ID="C0238198">Gastrointestinal stromal tumor</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1854336">Paragangliomas 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="23697" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5732" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SDHC-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (Paragangliomas 3)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602413.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomus tumors, familial, 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 3</ElementValue>
                <XRef ID="Paragangliomas+3/5580" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011544" DB="MONDO" />
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PPGL3</ElementValue>
                <XRef Type="MIM" ID="605373" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10545" />
                <XRef ID="10545" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2009">
                <ID Source="pmc">2668639</ID>
              </Citation>
              <Citation Type="review">
                <ID Source="PubMed">20816580</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Neuroendocrine and Adrenal Tumors, 2023</CitationText>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C1854336" DB="MedGen" />
              <XRef ID="MONDO:0011544" DB="MONDO" />
              <XRef Type="MIM" ID="605373" DB="OMIM" />
            </Trait>
            <Trait ID="2160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal Stromal Sarcoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal stromal tumor, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gastrointestinal stroma tumor</ElementValue>
                <XRef ID="HP:0100723" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gastrointestinal stromal tumor</ElementValue>
                <XRef ID="Gastrointestinal+Stromal+Tumors/2997" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011719" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GIST</ElementValue>
                <XRef Type="MIM" ID="606764" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KIT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8598" />
                <XRef ID="8598" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="UK NEQAS, 2012">
                <ID Source="PubMed">22685257</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gist.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastrointestinal Stromal Tumors, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, 2024</CitationText>
              </Citation>
              <XRef ID="44890" DB="Orphanet" />
              <XRef ID="C0238198" DB="MedGen" />
              <XRef ID="D046152" DB="MeSH" />
              <XRef ID="MONDO:0011719" DB="MONDO" />
              <XRef Type="MIM" ID="606764" DB="OMIM" />
              <XRef Type="primary" ID="HP:0100723" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2708206" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6770934|MedGen:C1854336;C0238198" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001373487" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change results in a premature translational stop signal in the SDHC gene (p.Lys117Valfs*89). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 53 amino acids of the SDHC protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SDHC-related conditions. This variant disrupts the C-terminus of the SDHC protein. Other variant(s) that disrupt this region (p.Arg133*) have been determined to be pathogenic (PMID:¬†23083876,¬†24423348, 24758179,¬†27700540). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.161326574_161326575del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1854336" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0238198" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2708206" TraitType="Disease" MappingType="XRef" MappingValue="C1854336" MappingRef="MedGen">
        <MedGen CUI="C1854336" Name="Paragangliomas 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2708206" TraitType="Disease" MappingType="XRef" MappingValue="C0238198" MappingRef="MedGen">
        <MedGen CUI="C0238198" Name="Gastrointestinal stromal tumor" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

